We are live on ! Find out more
MIP

Mondrian Investment Partners Portfolio holdings

AUM $6.48B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-4.13%
1 Year Est. Return
+18.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.57B
AUM Growth
–
Cap. Flow
+$6.8B
Cap. Flow %
103.58%
Top 10 Hldgs %
52.47%
Holding
87
New
87
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$829M
2
YUM icon
Yum! Brands
YUM
+$458M
3
BSMX
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
+$407M
4
BAP icon
Credicorp
BAP
+$404M
5
MR
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
+$319M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.7%
2 Financials 17.95%
3 Utilities 11.29%
4 Communication Services 10.36%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$40.8B
$834M 12.7%
+21,278,495
New +$829M
YUM icon
2
Yum! Brands
YUM
$41.8B
$461M 7.03%
+9,256,410
New +$458M
BSMX
3
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$371M 5.66%
+26,136,007
New +$407M
BAP icon
4
Credicorp
BAP
$31.8B
$357M 5.44%
+2,899,338
New +$404M
MR
5
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$302M 4.6%
+8,073,100
New +$319M
ENIA
6
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$278M 4.24%
+31,525,034
New +$301M
PHI icon
7
PLDT
PHI
$4.25B
$275M 4.18%
+4,045,525
New +$288M
ABV
8
DELISTED
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
$198M 3.02%
+5,304,400
New +$210M
AMX icon
9
America Movil
AMX
$76.1B
$192M 2.93%
+8,850,500
New +$181M
VALE.P
10
DELISTED
Vale S A
VALE.P
$176M 2.67%
+14,437,414
New +$214M
MSFT icon
11
Microsoft
MSFT
$3.45T
$130M 1.99%
+3,775,407
New +$124M
TSM icon
12
TSMC
TSM
$2.1T
$127M 1.94%
+6,957,578
New +$128M
PG icon
13
Procter & Gamble
PG
$336B
$99.7M 1.52%
+1,294,500
New +$102M
INTC icon
14
Intel
INTC
$455B
$98.6M 1.5%
+4,070,100
New +$96.1M
LVS icon
15
Las Vegas Sands
LVS
$31.7B
$98.1M 1.49%
+1,853,900
New +$104M
PFE icon
16
Pfizer
PFE
$143B
$96M 1.46%
+3,614,319
New +$99.9M
JNJ icon
17
Johnson & Johnson
JNJ
$618B
$93.6M 1.43%
+1,090,120
New +$92.5M
SYY icon
18
Sysco
SYY
$40.8B
$90.1M 1.37%
+2,636,700
New +$90.8M
BAX icon
19
Baxter International
BAX
$13.5B
$89.6M 1.36%
+2,381,334
New +$91.2M
CPL
20
DELISTED
CPFL Energia S.A.
CPL
$89.6M 1.36%
+5,180,639
New +$102M
BCE icon
21
BCE
BCE
$20.2B
$89M 1.36%
+2,064,700
New +$93.5M
NTRS icon
22
Northern Trust
NTRS
$33.3B
$87.1M 1.33%
+1,503,600
New +$84M
MDLZ icon
23
Mondelez International
MDLZ
$79.5B
$77.7M 1.18%
+2,724,100
New +$82.9M
UNH icon
24
UnitedHealth
UNH
$376B
$76.2M 1.16%
+1,164,000
New +$72.4M
BSAC icon
25
Banco Santander Chile
BSAC
$16.3B
$74.6M 1.14%
+3,049,288
New +$78.3M
1
2 3 4

Similar funds

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BFS
Bradley Foster & Sargent Hartford, Connecticut $6.44B AUM 25.27% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return

Mondrian Investment Partners's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Mondrian Investment Partners, which disclosed 87 positions worth $6.57B. Its ten largest holdings account for 52% of the portfolio.

Its largest position is Teva Pharmaceuticals: 21,278,495 shares worth $834M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, followed by Financials and Utilities.

  • Mondrian Investment Partners's largest Q2 2013 buy was Teva Pharmaceuticals: 21,278,495 shares worth $834M.
  • Mondrian Investment Partners's ten largest holdings make up 52% of its $6.57B portfolio in Q2 2013.
  • Mondrian Investment Partners disclosed 87 positions in Q2 2013, its first 13F filing on record.

Based on Mondrian Investment Partners's 13F filing for Q2 2013, filed 29 Jul 2013.